SCHEMBL22708929

SCHEMBL22708929

c1ccc(-c2ccc3c(c2)[nH]c2c4oc5ccccc5c4c4ccccc4c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 2/20 0.44
▸ MAP3K9 P80192 1/20 0.44
▸ MEN1 O00255 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CDK5 Q00535 4/20 0.40
▸ CDK5R1 Q15078 3/20 0.40
▸ TNKS2 Q9H2K2 1/20 0.40
▸ DYRK1A Q13627 2/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18132863 0.89 MAP3K11 (0.44) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL22708549 0.89 CDK5 (0.49) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL22708765 0.86 CDK5 (0.49) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL25471053 0.85 MAP3K11 (0.41) MAP3K11MAP3K9CDK4CCND1CDK5
SCHEMBL18346748 0.84 MAP3K11 (0.43) MAP3K11MAP3K9MAPTKMT2AKDM4E
SCHEMBL22708620 0.83 CDK5 (0.37) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL19428606 0.83 MEN1 (0.37) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL30883881 0.82 MAP3K11 (0.59) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL29506369 0.82 MAP3K11 (0.59) MAP3K11MAP3K9MEN1MAPTKMT2A
SCHEMBL17228831 0.82 MAP3K11 (0.59) MAP3K11MAP3K9MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 MAP3K11 2703/4885MAP3K9 2989/4885MEN1 279/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 MAP3K11 2703/4885MAP3K9 2989/4885MEN1 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback